MedPath

UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer Patients

Withdrawn
Conditions
Aspergillosis
Candidemia
C. Difficile
Registration Number
NCT01622595
Lead Sponsor
University of Arkansas
Brief Summary

OBSERVATIONAL STUDY OF INFECTIOUS COMPLICATIONS IN CANCER PATIENTS

Detailed Description

A NON-INTERVENTIONAL, OBSERVATIONAL STUDY OF INFECTIOUS COMPLICATIONS IN CANCER PATIENTS

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • cancer patients with Infections
Exclusion Criteria
  • No Infections

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the incidence, risk factors, clinical presentation, diagnosis and prognostic factors of infectious complications in cancer patients3 years

To study the incidence, risk factors, clinical presentation, diagnosis and prognostic factors of infectious complications in cancer patients

Secondary Outcome Measures
NameTimeMethod
incidence3 years

To determine the overall incidence of different infections, including bacterial, fungal and viral infections in cancer patients receiving chemotherapy and / or hematopoietic stem cell transplantation.

* To describe the natural history of such infections in cancer patients.

* To monitor the adherence of Myeloma institute for research and therapy(MIRT) health care workers to the MIRT standard operational procedures (SOPs)

* To identify risk factors for the development of specific infections.

* To validate surrogate markers as early diagnostic tools for various infections.

Trial Locations

Locations (1)

University of Arkansas for Medical Sciences

🇺🇸

Little Rock, Arkansas, United States

© Copyright 2025. All Rights Reserved by MedPath